bioequivalence
Showing 26 - 50 of 2,708
Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets
Not yet recruiting
- Healthy
- Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
- (no location specified)
Jul 26, 2023
Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))
Completed
- Healthy
- Gleptomet 50/1000(Metformin HCl & Sitagliptin)
- Janumet 50/1000(Metformin HCl & Sitagliptin)
-
Cairo, EgyptGenuine Research Center GRC
Mar 22, 2023
Drug Use Trial in Jakarta Pusat (Omeprazole 20 mg Capsules)
Completed
- Drug Use
- Omeprazole 20 mg Capsules
-
Jakarta Pusat, DKI Jakarta, IndonesiaPT Pharma Metric Labs
May 8, 2023
Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)
Active, not recruiting
- Bioequivalence
- Rivastigmine twice-weekly 9,5 mg/24 h
- Exelon® 9.5 mg/24 h
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023
Psoriasis and Psoriatic Arthritis Trial in Ahmedabad (Apremilast 30 mg Tablets, Otezla 30 mg film-coated tablets)
Completed
- Psoriasis and Psoriatic Arthritis
- Apremilast 30 mg Tablets
- Otezla 30 mg film-coated tablets
-
Ahmedabad, Gujarat, IndiaLambda Therapeutic Research Ltd.
Oct 18, 2023
Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)
Recruiting
- Bioequivalence
- RID-TDS 13.3 mg/24 h
- Exelon® 13.3 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023
Bioequivalence, Healthy Subjects Trial in Amman (Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium
Completed
- Bioequivalence
- Healthy Subjects
- Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
- Nurofen® Forte Express, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
-
Amman, JordanACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022
Healthy Volunteers Trial in Seoul (DWJ1558, DWC202310 and DWC202311)
Active, not recruiting
- Healthy Volunteers
- DWJ1558
- DWC202310 and DWC202311
-
Seoul, Korea, Republic ofH Plus YANGJI Hospital
Aug 28, 2023
Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)
Completed
- Healthy
- Test Empagliflozin And Linagliptin Tablets
- Reference Empagliflozin And Linagliptin tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023
Healthy Volunteers, Bioequivalence Study Trial in Karachi (Klaribact 500 mg Clarithromycin Tablet, Klaricid 500 mg
Completed
- Healthy Volunteers
- Bioequivalence Study
- Klaribact 500 mg Clarithromycin Tablet
- Klaricid 500 mg Clarithromycin Tablet
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research (CBSCR),
Aug 11, 2022
Healthy Male Subjects Trial (tafolecimab (a modified manufacturing process), tafolecimab (a original manufacturing process))
Not yet recruiting
- Healthy Male Subjects
- tafolecimab (a modified manufacturing process)
- tafolecimab (a original manufacturing process)
- (no location specified)
Mar 29, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence Trial in Edison (Oseltamivir Phosphate 75 mg capsules, Tamiflu capsules 75 mg)
Completed
- Bioequivalence
- Oseltamivir Phosphate 75 mg capsules
- Tamiflu capsules 75 mg
-
Edison, New JerseyAustarpharma Llc
Feb 1, 2023
Acute Myeloid Leukemia Trial in Tianjin ((cytarabine: daunorubicin) liposome for injection, Vyxeos)
Not yet recruiting
- Acute Myeloid Leukemia
- (cytarabine: daunorubicin) liposome for injection
- Vyxeos
-
Tianjin, ChinaInstitute of Hematology and Hospital of Blood Disease, Chinese A
Mar 24, 2023
Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor Trial in Changchun (Sunitinib malate
Completed
- Gastrointestinal Stromal Tumors
- +2 more
- Sunitinib malate capsules generic product
- Sunitinib malate capsules reference product
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 6, 2023
Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)
Not yet recruiting
- Viral Infection COVID-19
-
Saint Petersburg,, Russian FederationLimited Liability Company "Research Center Eco-Safety"
Oct 23, 2023
Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial
Recruiting
- Bioequivalence
- efgartigimod PH20 SC as a prefilled syringe presentation
- efgartigimod PH20 SC as a vial + syringe presentation
-
Tempe, Arizona
- +1 more
Apr 5, 2023
Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)
Completed
- Melanoma
- +3 more
- Binimetinib Oral Tablet
-
Rennes, FranceBiotrial
Mar 31, 2023